(Q30357693)

20 June 2017

title

Scientific lessons from the first influenza pandemic of the 20th century. (English)

1 reference

20 June 2017

0 references

pandemic preparedness

1 reference

1 reference

Oxford JS

1

1 reference

20 June 2017

Lambkin R

2

1 reference

20 June 2017

Elliot A

3

1 reference

20 June 2017

Daniels R

4

1 reference

20 June 2017

Sefton A

5

1 reference

20 June 2017

Gill D

6

1 reference

20 June 2017

language of work or name

English

0 references

publication date

16 June 2006

1 reference

20 June 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

20 June 2017

volume

24

1 reference

20 June 2017

issue

44-46

1 reference

20 June 2017

page(s)

6742-6746

1 reference

Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

Oral oseltamivir treatment of influenza in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

Characterization of the 1918 influenza virus polymerase genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

The structure and receptor binding properties of the 1918 influenza hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

Characterization of the reconstructed 1918 Spanish influenza pandemic virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

Transmissibility of 1918 pandemic influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.101

10.1016/J.VACCINE.2006.05.101

7 January 2021

Identifiers

DOI

1 reference

20 June 2017

1 reference